Caroline Diorio
Chercheuse universitaire
Axe Oncologie
Épidémiologie
Épidémiologie nutritionnelle
Santé publique et santé des populations
Étiologie des maladies et des affections
Cancer
Épigénétique et épigénomique
Publications
View all-
article Badre O, Chang SL, Abdous B, Lemieux J, Durocher F, Tchernof A, Diorio C
Mammary Adipocyte Size, Obesity-Related Breast Adipose Tissue Dysfunction, and Breast Cancer: A Systematic Review and Meta-Analysis
Cancers (Basel) 18 (15), 2026.
-
article Bherer J, Clemenceau A, Diorio C, Durocher F
Bazedoxifene and Beyond: Identifying This SERMs Targets and Deciphering Its Molecular Mechanisms
Adv Pharmacol Pharm Sci 2026 2026.
-
article Bruxelles Q, Hamel-Côté G, Scott-Boyer MP, Ouellette V, C-Gaudreault R, Durocher F, Diorio C, Droit A, Fortin S
FOXA1 and RAB25 as Biomarkers of Breast Cancer Cell Response to CYP1A1-Activated Prodrugs: Insights from CEU-938
Pharmaceuticals (Basel) 19 (3), 2026.
Projects
- Axe banque de tissus et de données BTD, from 2011-04-01 to 2027-03-31
- Impact of obesity and epigenetic markers on the efficacy of aromatase inhibitors treatments., from 2015-06-26 to 2026-12-31
- Omega-3 fatty acids in the prevention of breast cancer: role of obesity-related markers in breast tissues, from 2018-10-01 to 2027-03-31
- L’AIMZ-938, un nouveau promédicament anticancéreux pour le traitement des cancers du sein humain réfractaires aux traitements actuels et exprimant le cytochrome P450 1A1, from 2021-10-01 to 2026-09-30
- Management of sleeve gastrectomy failure using single-anastomosis metabolic surgery, from 2021-10-01 to 2026-09-30
- TBC1D9: therapeutic target of the aggressiveness of triple negative breast cancer, from 2023-03-01 to 2027-03-31
- Tirer profit des données de soins en contexte réel pour une introduction responsable, efficiente et équitable des innovations thérapeutiques en oncologie : la plateforme MEDOnco-VieRéelle, from 2024-09-01 to 2027-08-31
- Impact des marqueurs épigénétiques du tissu adipeux mammaire sur l'efficacité des traitements par inhibiteurs de l'aromatase chez les femmes atteintes d'un cancer du sein hormono-dépendant, from 2024-09-10 to 2027-06-30
- Development of statistical methods for estimating optimal adaptive treatment strategies with survival outcomes, from 2024-10-01 to 2028-09-30
- Stresseurs chroniques au travail, biomarqueurs endocriniens et atteintes à différentes étapes du continuum cardiovasculaire : une étude pilote, from 2026-04-01 to 2027-03-31
- Mutation Timing as Predictor of Breast Cancer Outcomes, from 2026-01-04 to 2027-03-31
- Deciphering breast cancer HER2-negativity with regard to HER2-targeted therapy, from 2016-07-01 to 2026-03-31
- Effect of environmental contaminants and methylome of breast adipose tissue on aromatase inhibitor efficacy in breast cancer, from 2016-07-01 to 2025-03-31
- Design for Better Health: User-Centred Design and Evaluation of Interactive Media for Health Education, Communication and Decision-Making, from 2016-07-01 to 2025-03-31
- Breast adipocyte hypertrophy: a novel biomarker to predict breast cancer survival, from 2022-01-01 to 2024-12-31
- What are my options? A feasibility study of a personalized primary prevention strategy for women and men at high risk of breast and prostate cancer, from 2022-01-15 to 2026-03-31
- The effect of cannabinoid receptors on breast cancer survival, from 2022-09-01 to 2026-05-31
- Vers des trajectoires de soins en cancer du sein personnalisées en fonction du risque et des besoins des patientes: une étude de faisabilité et d'acceptabilité, from 2023-04-01 to 2026-07-31
- Tumor biobanking was supported...Fondation du cancer du sein du Québec and the Banque de tissus...of the Réseau...(RRCancer)...by the Oncopole, the FRQS cancer hub,...Ministère de l'Économie, de l'Innovation et de l'Énergie du Québec., from 2023-04-01 to 2026-03-31
- Developing a breast cancer data access platform, from 2024-09-01 to 2026-08-31
- MOHCCN: Deciphering heterogeneity of rare metaplastic breast carcinoma Gold Cohort through spatialomics, from 2024-08-01 to 2026-03-31